Intellectual Property India Publishes Patent Application for Myt1 Inhibitors For The Treatment Of Cancers Harboring Replication Stress Mutations

MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617050940 A) filed by Repare Therapeutics Inc. on April 21, 2026, for Myt1 Inhibitors For The Treatment Of Cancers Harboring Replication Stress Mutations.

Inventors include Veloso, Artur; Fourtounis, Jimmy; and Marshall, Gary.

The application for the patent was published on September 11, 2026, under issue no. 37/2026.

Abstract: Disclosed herein are methods of using Myt1 inhibitors, alone and in combination with a second therapeutic agent, to effectively treat RAS (e.g., KRAS) mutant cancers.

Disclaimer: Curated by HT Syndication....